Who Attends
Patients as Partners EU is where pharma and patient advocacy leadership share best practices on the implementation of patient partnering to drive greater efficiencies in medicines development. Each session demonstrates the what, where, when and how to co-create solutions with patients and measure the impact of those initiatives. Together we are advancing patient participation for greater diversity, access and better clinical outcomes.
Patients as Partners EU Attendees Get Access to the Following Benefits:
• 50+ Multi-stakeholder speakers
• 17+ Hours of discussion
• 17+ Sessions covering strategies to involve patients in medicines development
• 10+ Networking activities
• 14+ Pharmaceutical company and patient-led presentations on a specific example of collaborating with patients
10 Essential Topic Areas Covered
- Advancing Integrated Patient Engagement
- Patient Experience Data and Data Return
- Understanding Patient Preferences in Clinical Trials
- Reversing Protocol Complexity to Ease Patient Burden
- Operationalizing Early Patient Insights for Measurable Impact
- Collaborative Approaches to Advance Representativeness in Clinical Trials
- Patient Perspectives on Supporting Mental Health in Clinical Trials
- Addressing Barriers to Cross Border Clinical Trials Access
- Deploying AI to Better Understand and Integrate Patient Insights
- HTA/Regulatory Requirements and Patient Engagement in Drug Development
Join 250+ Leaders from
Industry Segments
• Mid-to-large pharma
• Biotech (all sizes)
• Patient Advocacy Organizations
• Government
• CROs
• Clinical technology, mobile, digital, AI and service companies
• Academia
Titles/ Functions
• Heads of Patient Engagement/ Involvement/ Recruitment
• VPs/ Directors of Clinical Operations & Outsourcing
• Heads of Patient Advocacy
• Clinical Development Innovation Directors
• VPs of Clinical Affairs
• Clinical External Alliance Directors
2026 Sponsors
